1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015; 65:5–29.
2. Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer. 1987; 55:61–66.
3. Ratanatharathorn V, Powers WE, Steverson N, Han I, Ahmad K, Grimm J. Bone metastasis from cervical cancer. Cancer. 1994; 73:2372–2379.
4. Matsuyama T, Tsukamoto N, Imachi M, Nakano H. Bone metastasis from cervix cancer. Gynecol Oncol. 1989; 32:72–75.
5. Thanapprapasr D, Nartthanarung A, Likittanasombut P, Na Ayudhya NI, Charakorn C, Udomsubpayakul U, et al. Bone metastasis in cervical cancer patients over a 10-year period. Int J Gynecol Cancer. 2010; 20:373–378.
6. Yoon A, Choi CH, Kim HJ, Park JY, Lee YY, Kim TJ, et al. Contributing factors for bone metastasis in uterine cervical cancer. Int J Gynecol Cancer. 2013; 23:1311–1317.
7. Kanayama T, Mabuchi S, Shimura K, Hisamatsu T, Isohashi F, Hamasaki T, et al. Prognostic factors for survival in cervical cancer patients with bone metastasis. Eur J Gynaecol Oncol. 2015; 36:290–293.
8. Katagiri H, Takahashi M, Wakai K, Sugiura H, Kataoka T, Nakanishi K. Prognostic factors and a scoring system for patients with skeletal metastasis. J Bone Joint Surg Br. 2005; 87:698–703.
9. Katagiri H, Okada R, Takagi T, Takahashi M, Murata H, Harada H, et al. New prognostic factors and scoring system for patients with skeletal metastasis. Cancer Med. 2014; 3:1359–1367.
10. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982; 5:649–655.
11. Harrington KD. Orthopaedic management of extremity and pelvic lesions. Clin Orthop Relat Res. 1995; (312):136–147.
12. Harrington KD, Sim FH, Enis JE, Johnston JO, Diok HM, Gristina AG. Methylmethacrylate as an adjunct in internal fixation of pathological fractures. Experience with three hundred and seventy-five cases. J Bone Joint Surg Am. 1976; 58:1047–1055.
13. Cybulski GR, Von Roenn KA, D'Angelo CM, DeWald RL. Luque rod stabilization for metastatic disease of the spine. Surg Neurol. 1987; 28:277–283.